{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-283139","form_type":"8-K","ticker":"JAGX","cik":"0001585608","company_name":"Jaguar Health, Inc.","filed_at":"2025-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.832168+00:00","generated_at":"2026-05-16T19:51:33.894175+00:00","sec_items":["1.01","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Jaguar Health issues $10.81M secured note to Streeterville Capital; $8M held as collateral","bullets":["Net proceeds of $10M after $800K OID and $10K transaction expenses; interest 8% p.a., maturity 36 months.","$8M deposited in restricted account at Lakeside Bank as collateral; release allowed for excess over declining requirement.","Lender can redeem up to $600K/month starting month 12; mandatory prepayment of 25% of upfront IP licensing fees.","Note secured by subsidiary guaranty (JAGX Holdings) and pledge of all its membership interests; strict negative covenants on additional debt and equity.","Proceeds at Company's discretion, including repayment of $6M June 2025 convertible bridge notes."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-283139","json":"https://secwatch.observer/filing/0001193125-25-283139.json","markdown":"https://secwatch.observer/filing/0001193125-25-283139.md","text":"https://secwatch.observer/filing/0001193125-25-283139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525283139/0001193125-25-283139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525283139/d930413d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:51:33.894175+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e44180641c5c9ff092fa393e44b08db6e94b9935","claim":"Jaguar Health, Inc. incurred loan of $10,810,000 with Streeterville Capital, LLC at 8.00% per annum maturing 36 months following the date of issuance.","evidence_excerpt":"the Company issued and sold to the Lender a secured promissory note in the original principal amount of $10,810,000","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312525283139/0001193125-25-283139-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"loan"},{"label":"Principal","value":"$10,810,000"},{"label":"Counterparty","value":"Streeterville Capital, LLC"},{"label":"Rate","value":"8.00% per annum"},{"label":"Maturity","value":"36 months following the date of issuance"},{"label":"Event","value":"incurrence"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}